Rôle de l'herpèsvirus humain de type 6 dans le ... - Epublications

Lancet 2, 390.
Dutton, A., Reynolds, G. M., Dawson, C. W., Young, L. S. & Murray, P. G. (2005).
Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of
Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. J
Pathol 205, 498-506.
Dworzak, M. N., Fritsch, G., Buchinger, P., Fleischer, C., Printz, D., Zellner, A.,
Schollhammer, A., Steiner, G., Ambros, P. F. & Gadner, H. (1994). Flow cytometric
assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.
Blood 83, 415-425.
Ekstrand, B. C. & Horning, S. J. (2002). Hodgkin's disease. Blood Rev 16, 111-117.
Ekstrand, B. C., Lucas, J. B., Horwitz, S. M., Fan, Z., Breslin, S., Hoppe, R. T., Natkunam,
Y., Bartlett, N. L. & Horning, S. J. (2003). Rituximab in lymphocyte-predominant
Hodgkin disease: results of a phase 2 trial. Blood 101, 4285-4289.
Emery, V. C., Atkins, M. C., Bowen, E. F., Clark, D. A., Johnson, M. A., Kidd, I. M.,
McLaughlin, J. E., Phillips, A. N., Strappe, P. M. & Griffiths, P. D. (1999).
Interactions between beta-herpesviruses and human immunodeficiency virus in vivo:
evidence for increased human immunodeficiency viral load in the presence of human
herpesvirus 6. J Med Virol 57, 278-282.
Emmerich, F., Theurich, S., Hummel, M., Haeffker, A., Vry, M. S., Dohner, K., Bommert,
K., Stein, H. & Dorken, B. (2003). Inactivating I kappa B epsilon mutations in
Hodgkin/Reed-Sternberg cells. J Pathol 201, 413-420.
Enblad, G., Sandvej, K., Lennette, E., Sundstrom, C., Klein, G., Glimelius, B. & Pallesen,
G. (1997). Lack of correlation between EBV serology and presence of EBV in the
Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Int J Cancer 72,
394-397.
Enders, G., Biber, M., Meyer, G. & Helftenbein, E. (1990). Prevalence of antibodies to human
herpesvirus 6 in different age groups, in children with exanthema subitum, other acute
exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other
herpesviruses and HIV. Infection 18, 12-15.
Fiumara, P., Snell, V., Li, Y., Mukhopadhyay, A., Younes, M., Gillenwater, A. M.,
Cabanillas, F., Aggarwal, B. B. & Younes, A. (2001). Functional expression of receptor
activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 98, 2784-2790.
Flamand, L., Gosselin, J., D'Addario, M., Hiscott, J., Ablashi, D. V., Gallo, R. C. &
Menezes, J. (1991). Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis
factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol
65, 5105-5110.
Flamand, L., Gosselin, J., Stefanescu, I., Ablashi, D. & Menezes, J. (1995).
Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of
interleukin-2 synthesis and cell proliferation. Blood 85, 1263-1271.
Flavell, K. J., Billingham, L. J., Biddulph, J. P., Gray, L., Flavell, J. R., Constandinou, C.
M., Young, L. S. & Murray, P. G. (2003). The effect of Epstein-Barr virus status on
outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease.
Ann Oncol 14, 282-290.
Flebbe-Rehwaldt, L. M., Wood, C. & Chandran, B. (2000). Characterization of transcripts
expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17
open reading frames. J Virol 74, 11040-11054.
Foss, H. D., Reusch, R., Demel, G., Lenz, G., Anagnostopoulos, I., Hummel, M. & Stein, H.
166